News Focus
News Focus
icon url

runncoach

11/15/22 8:39 AM

#20582 RE: FooBarAndGrill #20581

40 weeks is a secondary endpoint, observational only. Final efficacy endpoint from dosing is at 28 weeks and that's what we will get in a few weeks. 3 months later they go back and see how long the proposed benefit persists in patients.